Previous data demonstrate that CCL3 (MIP-1α) and CCL4 (MIP-1b) control the infiltration of the immune cells by recruiting antigen-presenting cells, including dendritic cells (DCs), to the tumor site via IFN-γ [52]. The gene discussed is CCL3; the disease is neoplasm.